Nasdaq nmra.

Sep 21, 2023 · Shares of Neumora Therapeutics (NMRA 0.41%) were down more than 32% for the week as of Thursday's market close, according to data provided by S&P Global Market Intelligence. Find the latest news headlines from Neumora Therapeutics, Inc. Common Stock (NMRA) at Nasdaq.com.Sep 21, 2023 · Shares of Neumora Therapeutics (NMRA 0.41%) were down more than 32% for the week as of Thursday's market close, according to data provided by S&P Global Market Intelligence. CGC. Canopy Growth Corporation Common Shares. $1.275 -0.065 -4.85%. Find the latest SEC Filings data for Neumora Therapeutics, Inc. Common Stock (NMRA) at Nasdaq.com.

NMRA-140 protected WM performance from the detrimental effects of FG7142-induced stress and exhibited no significant effect under non-stress conditions. Collectively, these data highlight the functional influence of the KOR system in mediating stress-induced dysfunction of executive processes and suggest that modulating KOR …Home NMRA • NASDAQ Neumora Therapeutics Inc Follow Share $11.92 Nov 24, 5:45:00 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Sezzle Inc $10.20 SEZL5.38% WK Kellogg Co $12.15...

Nasdaq | NMRA U.S.: Nasdaq Neumora Therapeutics Inc. Watch list NEW Set a price target alert After Hours Last Updated: Oct 4, 2023 7:35 p.m. EDT Delayed quote $ 12.27 0.36 3.02% After Hours...Visualize o gráfico de Neumora Therapeutics, Inc. ao vivo para acompanhar o movimento do preço de suas ações. Encontre previsões de mercado, NMRA finanças e notícias do …

NASDAQ: NMRA. Membeli atau menjual saham yang tidak diperdagangkan dalam mata uang lokal Anda? Jangan biarkan konversi mata uang membuat Anda rugi. Konversi saham atau unit saham Neumora Therapeutics Inc. Common Stock ke mata uang apa pun dengan alat praktis kami, dan Anda akan selalu tahu apa yang Anda dapatkan.Neumora Therapeutics, Inc. (NASDAQ:NMRA) as filed to raise $100 million in an IPO of its common stock, according to an SEC S-1 registration statement.Victor J. Blue/Bloomberg. Shares of Watertown biotech Neumora Therapeutics retreated 4.4 percent Friday, in the company’s debut on the Nasdaq stock exchange, after it raised $250 million in an ...Watch Nasdaq's Neumora Therapeutics [NMRA] Rings the Nasdaq Opening Bell on Livestream.com.Canopy Growth Corporation Common Shares. $1.165 -0.175 -13.06%. NVDA. NVIDIA Corporation Common Stock. $449.995 +1.295 +0.29%. Neumora Therapeutics, Inc. Common Stock (NMRA) Advanced Charting ...

NMRA | Complete Neumora Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

SpringWorks Therapeutics Inc (NASDAQ:SWTX)’s traded shares stood at 0.46 million during the last session, with the company’s beta value hitting 0.58. At the close of trading, the stock’s price was $20.71, to imply a decrease of -2.08% or -$0.44 in intraday trading. The SWTX share’s 52-week ...

Neumora Therapeutics, Inc. Common Stock (NMRA) Option Chain | Nasdaq. Call and put options are quoted in a table called a chain sheet. The chain sheet shows the price, volume and open interest for ...Uncover the latest insider trading activity for Neumora Therapeutics, Inc. (NMRA). Know which insiders are buying and selling along with top shareholders and ownership breakdown. Dashboard Markets Discover Watchlist Portfolios Screener. Neumora Therapeutics, Inc. NasdaqGS:NMRA Stock Report. Mkt Cap: US$1.8b.Nov 9, 2023 · Neumora Therapeutics, Inc. ( NASDAQ:NMRA – Get Free Report) Director Kristina Burow bought 43,082 shares of the business’s stock in a transaction dated Monday, November 6th. The stock was ... 15 Sep 2023 ... View today's Neumora Therapeutics Inc stock price and latest NMRA news and analysis. Create real-time notifications to follow any changes in ...NMRA-266 is a highly selective positive allosteric modulator of the M4 muscarinic receptor that Neumora is developing as a treatment for schizophrenia and …6 hari yang lalu ... (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced that the Company will ...

The latest price target for Harmony Biosciences ( NASDAQ: HRMY) was reported by Needham on Wednesday, November 1, 2023. The analyst firm set a price target for 53.00 expecting HRMY to rise to ...Nasdaq | NMRA U.S.: Nasdaq Neumora Therapeutics Inc. Watch list NEW Set a price target alert After Hours Last Updated: Oct 4, 2023 7:35 p.m. EDT Delayed quote $ 12.27 0.36 3.02% After Hours...Nov 1, 2023 · Successfully completed initial public offering: In September 2023, Neumora completed its initial public offering of its common stock and shares began trading on the Nasdaq Global Select Market under the ticker symbol “NMRA.” Since its inception, Neumora has raised over $850 million to further its mission to confront the global brain disease ... Christoph Burgstedt/iStock via Getty Images. Company logo. I started a long position in Neumora Therapeutics, Inc. (NASDAQ:NMRA) last week with a 4.2% portfolio allocation.This recent central ...NMRA's current price target is $22.67. Learn why top analysts are making this stock forecast for Neumora Therapeutics at MarketBeat. ... NASDAQ:NMRA. Neumora Therapeutics (NMRA) Stock Forecast & Price Target $11.69-0.16 (-1.35%) (As of 11/21/2023 ET) Add Compare. Share . Share .The latest Neumora Therapeutics stock prices, stock quotes, news, and NMRA history to help you invest and trade smarter ... Nasdaq Live · World Map · The word ...

For Neumora Therapeutics Inc (NASDAQ:NMRA), William Blair initiated coverage, by setting the current rating at Outperform. The stock has a 52-week-high of $17.74 and a 52-week-low of $9.90.

Complete Neumora Therapeutics Inc. stock information by Barron's. View real-time NMRA stock price and news, along with industry-best analysis.Nemaura Medical, Inc. Common Stock (NMRD) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.NMRA-266 is a highly selective positive allosteric modulator of the M4 muscarinic receptor that Neumora is developing as a treatment for schizophrenia and other neuropsychiatric disorders.15 Sep 2023 ... View today's Neumora Therapeutics Inc stock price and latest NMRA news and analysis. Create real-time notifications to follow any changes in ...WATERTOWN, Mass., Oct. 30, 2023 -- Neumora Therapeutics, Inc. , a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced that the Company will...Sep 26, 2023 · Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements. Close Trending Tickers bar Neumora Therapeutics, Inc.(NasdaqGS:NMRA) added to NASDAQ Composite Index Sep. 18: CI Neumora Therapeutics, Inc. has completed an IPO in the amount of $250.07 million. ... (NMRA-140), is a novel once-daily oral kappa opioid receptor (KOR) antagonist in Phase 3 development as a potential monotherapy treatment for …

Find the latest Financials data for Neumora Therapeutics, Inc. Common Stock (NMRA) at Nasdaq.com.

Neumora Therapeutics, Inc. (NASDAQ:NMRA) as filed to raise $100 million in an IPO of its common stock, according to an SEC S-1 registration statement.

Canopy Growth Corporation Common Shares. $1.165 -0.175 -13.06%. NVDA. NVIDIA Corporation Common Stock. $449.995 +1.295 +0.29%. Neumora Therapeutics, Inc. Common Stock (NMRA) Advanced Charting ...Successfully completed initial public offering: In September 2023, Neumora completed its initial public offering of its common stock and shares began trading on the Nasdaq Global Select Market under the ticker symbol “NMRA.” Since its inception, Neumora has raised over $850 million to further its mission to confront the global brain disease ...Kymera Therapeutics Inc (NASDAQ:KYMR)’s traded shares stood at 0.36 million during the last session, with the company’s beta value hitting 2.03. At the close of trading, the stock’s price was $19.74, to imply an increase of 4.11% or $0.78 in intraday trading. The KYMR share’s 52-week high ...Find the latest Financials data for Neumora Therapeutics, Inc. Common Stock (NMRA) at Nasdaq.com.3 hari yang lalu ... Neumora Therapeutics Inc (NASDAQ: NMRA) gained 15.4% to $14.00 in pre-market trading. Neumora Therapeutics recently initiated a Phase 1 ...The stock is expected to list on the Nasdaq under the ticker symbol “NMRA.” J.P. Morgan, BofA Securities, Guggenheim Securities, RBC Capital Markets and William Blair are the underwriters. The ...THIRD QUARTER 2023 FINANCIAL RESULTS. The Company reported a net loss of $53.0 million for the third quarter of 2023, as compared to $29.3 million for the same period in 2022. Research and ...View live price data for NMRA (Neumora Therapeutics, Inc.) on TrendSpider to track real-time price action, options flow, and news on this asset and hundreds more. Dark Light. Search Ctrl + K. Login Try full version. Smart Watchlists. NMRA. NMRA. Neumora Therapeutics, Inc. 10.02 USD +0.38 (+3.94%) Last updated Oct 13, 21:00 UTC. …NMRA | Complete Neumora Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.When is Neumora Therapeutics (NASDAQ:NMRA) reporting earnings? A. Neumora Therapeutics ( NMRA) is scheduled to report earnings on February 15, 2024. The last reported earnings were for reported on ...Nov 27, 2023 · NMRA-266 is a highly selective positive allosteric modulator of the M4 muscarinic receptor that Neumora is developing as a treatment for schizophrenia and other neuropsychiatric disorders.

Indivior Stock (NASDAQ: INDV) stock price, news, charts, stock research, profile.NMRA | Complete Neumora Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.6 hari yang lalu ... (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced that the Company will ...Neumora Therapeutics press release (NASDAQ:NMRA): Q3 GAAP EPS of -$1.14 misses by $0.74. $519.5 million in cash, cash equivalents and marketable securities expected to support operations into 2026.Instagram:https://instagram. i c l companybest no fee travel cardbest mortgage lenders in mashaquille o'neal shoes at walmart Nov 24, 2023 · Posted by Defense World Staff on Nov 24th, 2023. Shares of Neumora Therapeutics, Inc. ( NASDAQ:NMRA – Get Free Report) gapped up prior to trading on Wednesday . The stock had previously closed ... cmpygm financials The latest price target for Neumora Therapeutics (NASDAQ: NMRA) was reported by JP Morgan on Wednesday, November 8, 2023. The analyst firm set a price target ...Andrey Tolkachev/iStock via Getty Images. Neumora Therapeutics (NASDAQ:NMRA) stock dipped 4% in late afternoon trading Friday following a $250M IPO.Shares of the psychiatric drug developer opened ... landlord insurance california Neumora Therapeutics (NASDAQ:NMRA), a biotech company focused on developing treatments for neurodegenerative diseases such as Alzheimer’s and Parkinson’s, went public on September 15th with an ...Visualize o gráfico de Neumora Therapeutics, Inc. ao vivo para acompanhar o movimento do preço de suas ações. Encontre previsões de mercado, NMRA finanças e notícias do …Neumora Therapeutics, Inc. Common Stock stock price (NMRA) NASDAQ: NMRA. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Neumora Therapeutics, Inc. Common Stock stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.